Clinical Trial Update: Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies） [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a triplet regimen of sintilimab, bevacizumab, and decitabine for advanced metastatic colorectal cancer after at least two…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• Dacogen (decitabine) (decitabine)
• Tyvyt (Sintilimab) (Sintilimab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING